$ Value
$0
Shares
1,987
Price
$0
Filed
Dec 29
Insider
Name
Schorno Dean L
Title
EVP & Chief Financial Officer
CIK
0001509688
Roles
Transaction Details
Transaction Date
2025-12-22
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
14,262
Footnotes
These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. | Includes 500 shares of common stock acquired under the Issuer's stock purchase plan. | The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019, subject to the reporting person's continuous service to the Issuer through each such period. | The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the Issuer through each such period. | The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer through each such period.
Filing Info
Schorno Dean L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-17 | RIGL | A | $0 |
| 2026-02-10 | RIGL | F | $123K |
| 2026-02-02 | RIGL | F | $198K |
| 2025-12-22 | RIGL | M | $40K |
| 2025-12-22 | RIGL | M | $69K |
| 2025-12-22 | RIGL | M | $31K |
| 2025-12-22 | RIGL | M | $0 |
| 2025-12-22 | RIGL | M | $0 |
| 2025-12-22 | RIGL | M | $0 |
| 2025-09-15 | RIGL | A | $0 |
Other Insiders at RIGL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MOOS WALTER H | — | $145K | 2026-02-20 |
|
RODRIGUEZ RAUL R
CEO, President
|
— | — | 2026-02-17 |
| MILLER MICHAEL PATRICK | — | — | 2026-02-01 |
|
Schorno Dean L
EVP & Chief Financial Officer
|
— | — | 2026-02-17 |
|
Furey Raymond J.
EVP, GC, CCO & Corp Sec
|
— | — | 2026-02-17 |
|
Santos David A
EVP, Chief Commercial Officer
|
— | — | 2026-02-17 |
|
Rojkjaer Lisa
EVP, Chief Medical Officer
|
— | — | 2026-02-17 |